Patents by Inventor Rachel Roper

Rachel Roper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9028837
    Abstract: The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: May 12, 2015
    Assignee: East Carolina University
    Inventor: Rachel Roper
  • Publication number: 20130251746
    Abstract: The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
    Type: Application
    Filed: December 20, 2012
    Publication date: September 26, 2013
    Applicant: East Carolina University
    Inventor: Rachel Roper
  • Publication number: 20120294896
    Abstract: The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
    Type: Application
    Filed: June 7, 2012
    Publication date: November 22, 2012
    Inventor: Rachel Roper
  • Patent number: 8202521
    Abstract: The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: June 19, 2012
    Assignee: East Carolina University
    Inventor: Rachel Roper
  • Patent number: 7897744
    Abstract: The invention provides, in part, the genomic sequence of a putative coronavirus, the SARS virus, and provides novel nucleic acid and amino acid sequences that may be used, for example, for the diagnosis, prophylaxis, or therapy of a variety of SARS virus related disorders.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: March 1, 2011
    Assignee: The Public Health Agency of Canada
    Inventors: Frank Plummer, Heinz Feldmann, Steven Jones, Yan Li, Nathalie Bastien, Robert Conrad Brunham, Angela Brooks-Wilson, Robert Holt, Christopher Upton, Rachel Roper, Caroline Astell, Steven Jones
  • Publication number: 20090155244
    Abstract: The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.
    Type: Application
    Filed: March 1, 2006
    Publication date: June 18, 2009
    Inventor: Rachel Roper
  • Publication number: 20070258999
    Abstract: The invention provides, in part, the genomic sequence of a putative coronavirus, the SARS virus, and provides novel nucleic acid and amino acid sequences that may be used, for example, for the diagnosis, prophylaxis, or therapy of a variety of SARS virus related disorders.
    Type: Application
    Filed: April 28, 2004
    Publication date: November 8, 2007
    Applicant: THE PUBLIC HEALTH AGENCY OF CANADA
    Inventors: Frank Plummer, Heinz Feldmann, Steven Jones, Yan Li, Nathalie Bastien, Robert Brunham, Angela Brooks-Wilson, Robert Holt, Christopher Upton, Rachel Roper, Caroline Astell, Steven Jones